Screener
Neuropace, Inc. NPCE Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
| (in thousands, except for share and per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of goods sold | 3,920 | 3,288 | 7,912 | 6,478 |
| Gross profit | 18,906 | 16,213 | 36,917 | 31,344 |
| Operating expenses: | ||||
| Sales and marketing | 12,124 | 11,489 | 23,707 | 21,894 |
| Research and development | 6,898 | 6,845 | 14,087 | 14,285 |
| General and administrative | 5,027 | 6,068 | 9,871 | 10,114 |
| Total operating expenses | 24,049 | 24,402 | 47,665 | 46,293 |
| Loss from continuing operations | (5,143) | (8,189) | (10,748) | (14,949) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Neuropace, Inc.'s sales & marketing?
- Neuropace, Inc. (NPCE) reported sales & marketing of $12.12M in Q2 2026.
- How has Neuropace, Inc.'s sales & marketing changed year-over-year?
- Neuropace, Inc.'s sales & marketing increased by 5.5% year-over-year, from $11.49M to $12.12M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about Neuropace, Inc.'s sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude